Newsroom
- Press Release
13 December 24
CuraTeQ Biologics receives CHMP positive opinion for Filgrastim biosimilar
Read more - Press Release
12 November 24
EMA grants GMP certificate to CuraTeQ Biologics’ manufacturing facility in Hyderabad
Read more - Press Release
15 March 24
CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar
Read more